Skip to content
Nonprofiteer
← LIEBER INSTITUTE INC

Form 990 for tax year 2023

Filed by LIEBER INSTITUTE INC.

Totals

Total revenue
$31,261,351
Total expenses
$32,639,037
Contributions and grants received
$27,627,150
Grants paid
$1,347,916
Program service revenue
$1,856,612
Investment income
$1,713,673
Other revenue
$63,916
Total assets, end of year
$35,095,508
Total liabilities, end of year
$11,492,905
Net assets or fund balances, end of year
$23,602,603
Program services expenses (Part IX)
$27,183,048
Management and general expenses
$5,455,989
Fundraising expenses
$0
Program service expenses (Part III)
$27,183,048

Program services were 83.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $9,104,029

  • 1f · All other contributions, gifts and grants

    $18,523,121

  • 1g · Noncash contributions included above

    $15,729,019

  • 2a · Program service revenue: DRUG DISCOVERY

    total $1,406,108 · related or exempt $1,406,108

  • 2b · Program service revenue: CLINICAL SCIENCES

    total $448,364 · related or exempt $448,364

  • 2c · Program service revenue: BASIC SCIENCES

    total $2,140 · related or exempt $2,140

  • 3 · Investment income

    total $429,769 · excluded $429,769

  • 7a · Gross sales of assets other than inventory

    securities $28,754,476

  • 7b · Less cost or other basis and sales expenses

    securities $27,470,572

  • 7c · Gain or loss

    securities $1,283,904

  • 7d · Net gain or loss

    total $1,283,904 · excluded $1,283,904

  • 11a · Other revenue: TAX REFUND

    total $63,407 · excluded $63,407

  • 11d · All other revenue

    total $509 · excluded $509

  • 11e · Other revenue, total

    $63,916

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,347,916 · program services $1,347,916

  • 5 · Compensation of officers, directors and key employees

    total $2,446,984 · program services $1,599,139 · management and general $847,845

  • 7 · Other salaries and wages

    total $11,852,362 · program services $10,014,844 · management and general $1,837,518

  • 8 · Pension plan contributions

    total $513,401 · program services $401,236 · management and general $112,165

  • 9 · Other employee benefits

    total $1,516,493 · program services $1,175,871 · management and general $340,622

  • 10 · Payroll taxes

    total $930,643 · program services $711,812 · management and general $218,831

  • 11b · Fees: legal

    total $49,967 · program services $11,000 · management and general $38,967

  • 11c · Fees: accounting

    total $42,870 · management and general $42,870

  • 11f · Fees: investment management

    total $134,692 · management and general $134,692

  • 11g · Fees: other

    total $1,126,675 · program services $907,040 · management and general $219,635

  • 12 · Advertising and promotion

    total $28,824 · management and general $28,824

  • 13 · Office expenses

    total $1,256,465 · program services $1,039,975 · management and general $216,490

  • 14 · Information technology

    total $393,764 · program services $120,294 · management and general $273,470

  • 16 · Occupancy

    total $3,287,423 · program services $2,498,237 · management and general $789,186

  • 17 · Travel

    total $241,983 · program services $185,975 · management and general $56,008

  • 19 · Conferences, conventions and meetings

    total $64,635 · program services $41,812 · management and general $22,823

  • 22 · Depreciation, depletion and amortization

    total $1,370,328 · program services $1,214,394 · management and general $155,934

  • 23 · Insurance

    total $70,893 · management and general $70,893

  • 24a · Other expenses: GENERAL LAB SUPPLIES

    total $2,590,383 · program services $2,584,745 · management and general $5,638

  • 24b · Other expenses: OTHER LAB EXPENSES

    total $2,034,356 · program services $2,032,500 · management and general $1,856

  • 24c · Other expenses: LAB SERVICES

    total $1,287,181 · program services $1,286,644 · management and general $537

  • 24d · Other expenses: OTHER EXPENSES

    total $50,799 · program services $9,614 · management and general $41,185

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,607,216 · end of year $1,717,980

  • 2 · Savings and temporary cash investments

    beginning of year $937,502 · end of year $2,631,902

  • 4 · Accounts receivable

    beginning of year $1,733,028 · end of year $1,716,687

  • 9 · Prepaid expenses and deferred charges

    beginning of year $579,766 · end of year $699,319

  • 10a · Land, buildings and equipment: cost or other basis

    $25,665,587

  • 10b · Land, buildings and equipment: accumulated depreciation

    $22,138,793

  • 10c · Land, buildings and equipment, net

    beginning of year $4,691,657 · end of year $3,526,794

  • 11 · Investments: publicly traded securities

    beginning of year $18,259,016 · end of year $16,901,690

  • 13 · Investments: program-related

    beginning of year $2,431,210 · end of year $2,431,210

  • 15 · Other assets

    beginning of year $6,417,208 · end of year $5,469,926

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,912,707 · end of year $3,128,885

  • 19 · Deferred revenue

    beginning of year $1,160,422 · end of year $452,035

  • 25 · Other liabilities

    beginning of year $8,617,809 · end of year $7,911,985

  • 27 · Net assets without donor restrictions

    beginning of year $22,987,039 · end of year $23,602,603

  • 28 · Net assets with donor restrictions

    beginning of year $978,626 · end of year $0

Mission and programs · 2023

Mission

THE MISSION OF THE INSTITUTE IS TO TRANSLATE BASIC GENETIC AND MOLECULAR MECHANISMS OF SCHIZOPHRENIA AND RELATED DEVELOPMENTAL BRAIN DISORDERS INTO CLINICAL ADVANCES THAT CHANGE THE LIVES OF AFFECTED INDIVIDUALS. IT IS CATALYZING A NEW UNDERSTANDING OF BRAIN DISEASE BY LINKING ADVANCES IN THE CONSTRUCTION AND FUNCTION OF THE HUMAN BRAIN WITH THE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES.

  • CLINICAL SCIENCES: THE CLINICAL SCIENCE DIVISION INVESTIGATES MECHANISMS OF SCHIZOPHRENIA AND RELATED BRAIN DISORDERS IN CLINICAL STUDIES AND IN BIOLOGICAL MATERIAL FROM CLINICAL SAMPLES SPECIFICALLY ASCERTAINED, EVALUATED AND MANAGED BY INSTITUTE STAFF AND THROUGH COLLABORATIONS WITH JOHNS HOPKINS UNIVERSITY, THE NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH), UNIVERSITY OF BARI (ITALY), MEDICAL COLLEGE OF VIRGINIA, MORGAN STATE UNIVERSITY AND OTHERS.

    Expenses $3,868,786 · Grants $17,177 · Revenue $448,364

  • BASIC SCIENCES: THE CREATION OF MODEL SYSTEMS AT THE INSTITUTE TO STUDY PSYCHIATRIC ILLNESS IS THE MAJOR GOAL OF THE BASIC SCIENCES RESEARCH PROGRAM. USING OUR UNIQUE COLLECTION OF HUMAN BRAIN MATERIAL AND INDUCED PLURIPOTENT STEM CELL LINES, WE ARE DEFINING THE MOLECULAR SIGNATURE OF DISEASE RISK. TO PROVIDE THE BASIS FOR THERAPEUTIC INTERVENTION WE ARE DEVELOPING NEW TECHNOLOGIES USING HUMAN STEM CELLS TO IDENTIFY THE FUNCTIONAL CONSEQUENCES OF GENETIC RISK FACTORS. THE GOAL OF THESE STUDIES IS THE IDENTIFICATION OF THERAPEUTIC TARGETS BASED ON THE MECHANISMS OF DISEASE.

    Expenses $17,704,193 · Grants $1,330,739 · Revenue $2,140

  • DRUG DISCOVERY: IMPROVED GENETIC UNDERSTANDING OF DISEASES OF BRAIN DEVELOPMENT IS REVEALING NEW DRUG DISCOVERY OPPORTUNITIES. GUIDED BY GENETICS, THE INSTITUTE'S DRUG DISCOVERY DIVISION IS INVESTIGATING NEW TARGETS FOR PSYCHIATRIC DISEASES, WITH THE GOAL OF VALIDATING INNOVATIVE APPROACHES THAT WILL LEAD TO NOVEL MEDICINES FOR PATIENTS SUFFERING FROM THESE CONDITIONS. THE DRUG DISCOVERY DIVISION MAINTAINS A STATE OF THE ART MEDICINAL CHEMISTRY LABORATORY AND UNIQUE CAPABILITIES IN TARGET VALIDATION.

    Expenses $5,610,069 · Revenue $1,406,108

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Herbert Pardes MD

    CHAIRMAN OF THE BOARD

    Total calculated
    $0
    Hours/week
    1
  • Steven S Sharfstein MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Geoffrey Simon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mary Rubin

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Tamar Maltz

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Milton Maltz

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Robert Muse

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Daniel R Getts

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Landon S King

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Daniel R Weinberger

    CEO & DIRECTOR

    Total calculated
    $786,543
    From this org
    $758,489
    From related orgs
    $0
    Other
    $28,054
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $690,272
    Bonus
    $67,599
    Other
    $618
    Deferred
    $10,250
    Nontaxable benefits
    $17,804
    Filer's total
    $786,543
  • Thomas Michael Hyde

    CHIEF MEDICAL OFFICER

    Total calculated
    $454,034
    From this org
    $425,980
    From related orgs
    $0
    Other
    $28,054
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $404,180
    Bonus
    $21,076
    Other
    $724
    Deferred
    $10,250
    Nontaxable benefits
    $17,804
    Filer's total
    $454,034
  • Elaine Jones

    CHIEF OPERATING OFFICER

    Total calculated
    $440,330
    From this org
    $430,080
    From related orgs
    $0
    Other
    $10,250
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $407,847
    Bonus
    $2,400
    Other
    $19,833
    Deferred
    $10,250
    Nontaxable benefits
    $0
    Filer's total
    $440,330
  • Andrew Maslan

    CFO & TREASURER

    Total calculated
    $391,236
    From this org
    $357,638
    From related orgs
    $0
    Other
    $33,598
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $355,362
    Bonus
    $2,000
    Other
    $276
    Deferred
    $10,250
    Nontaxable benefits
    $23,348
    Filer's total
    $391,236
  • James Barrow

    ASSOC. DIR. OF DRUG DISCOV

    Total calculated
    $353,677
    From this org
    $319,918
    From related orgs
    $0
    Other
    $33,759
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $299,698
    Bonus
    $19,704
    Other
    $516
    Deferred
    $10,250
    Nontaxable benefits
    $23,509
    Filer's total
    $353,677
  • Joel E Kleinman

    ASSOC. DIR. OF CLINICAL SC

    Total calculated
    $386,614
    From this org
    $358,560
    From related orgs
    $0
    Other
    $28,054
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $336,866
    Bonus
    $21,076
    Other
    $618
    Deferred
    $10,250
    Nontaxable benefits
    $17,804
    Filer's total
    $386,614
  • Brady Maher

    LEAD INVESTIGATOR

    Total calculated
    $230,527
    From this org
    $197,647
    From related orgs
    $0
    Other
    $32,880
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $178,706
    Bonus
    $18,761
    Other
    $180
    Deferred
    $9,371
    Nontaxable benefits
    $23,509
    Filer's total
    $230,527
  • Shizhong Han

    LEAD INVESTIGATOR, DATA SC

    Total calculated
    $232,218
    From this org
    $199,635
    From related orgs
    $0
    Other
    $32,583
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $168,461
    Bonus
    $31,054
    Other
    $120
    Deferred
    $9,235
    Nontaxable benefits
    $23,348
    Filer's total
    $232,218
  • Keri Martinowich

    LEAD INVESTIGATOR

    Total calculated
    $257,618
    From this org
    $224,632
    From related orgs
    $0
    Other
    $32,986
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $192,452
    Bonus
    $32,000
    Other
    $180
    Deferred
    $9,477
    Nontaxable benefits
    $23,509
    Filer's total
    $257,618
  • Jean Dubose

    CHIEF OF STAFF

    Total calculated
    $238,243
    From this org
    $228,486
    From related orgs
    $0
    Other
    $9,757
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $222,310
    Bonus
    $5,900
    Other
    $276
    Deferred
    $9,757
    Nontaxable benefits
    $0
    Filer's total
    $238,243

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Housing allowance or residence for personal use
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 5a · Pay contingent on this organization's revenues

Answered no

  • 1b · Written policy on the line-1a expenses
  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 1A
PAYMENTS FOR HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE: THE INSTITUTE RENTS AN APARTMENT IN BALTIMORE, MD FOR ITS COO, ELAINE JONES, WHO COMMUTES WEEKLY FROM CAPE CHARLES, VIRGINIA. A DAILY COMMUTE FROM CAPE CHARLES, VA IS OVER 200 MILES EACH WAY, TOO GREAT OF A DISTANCE TO EXPECT A REASONABLE DAILY COMMUTE. THE VALUE OF THE HOUSING PROVIDED IS INCLUDED AS A TAXABLE BENEFIT TO ELAINE JONES.
PART I, LINE 1B
THE INSTITUTE PROVIDED PERSONAL HOUSING AS PART OF A NEGOTIATED COMPENSATION AND BENEFITS PACKAGE. THE INSTITUTE DID NOT ANTICIPATE REPEATING THIS ARRANGEMENT, AND THEREFORE DID NOT ESTABLISH A POLICY GOVERNING THIS TYPE OF ARRANGEMENT.
PART I, LINE 5
SOME BONUSES ARE CALCULATED BASED ON A PERCENTAGE OF CERTAIN PRE-DEFINED CATEGORIES OF RESEARCH-RELATED REVENUE. SUCH BONUSES ARE SUBJECT TO AN ANNUAL CAP OF $60,000.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$1,458,765

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES BASIC SCIENCES $24,168
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CLINICAL SCIENCES $62,500
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES DRUG DISCOVERY $335,874
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES DRUG DISCOVERY $1,010,813
NORTH AMERICA 0 0 PROGRAM SERVICES BASIC SCIENCES $25,410
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2023
Filed
14 May 2025
IRS schema version
2023v6.0
Source object
202541359349302514

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.